Pronóstico del mercado de opioides en Asia Pacífico hasta 2030: análisis regional, por producto (opioide de acción corta de liberación inmediata y opioide de acción prolongada de liberación prolongada), aplicación (manejo del dolor, anestesia, supresión de la diarrea, supresión de la tos, desintoxicación y otros), vía de administración (parche oral, inyectable y transdérmico) y canal de distribución (farmacias hospitalarias y farmacias minoristas)
La creciente incidencia del dolor crónico impulsa el mercado de opioides de Asia Pacífico
Las enfermedades crónicas como las enfermedades cardiovasculares, el cáncer, las enfermedades musculoesqueléticas y las enfermedades neurovasculares afectan gravemente la salud de una persona al reducir la inmunidad. Además, muchos pacientes que padecen estas afecciones experimentan dolor crónico. Las enfermedades mencionadas anteriormente son más comunes en adultos y en la población geriátrica. Sin embargo, los casos de estas enfermedades también están aumentando notablemente entre los niños. El dolor crónico también es común entre deportistas, atletas y personas que viven con lesiones pasadas. Según un estudio publicado en el NCBI (es decir, el Centro Nacional de Información Biotecnológica), el 20% de los adultos en todo el mundo sufren dolor y el 10% recibe un diagnóstico nuevo de dolor crónico cada año. Si bien el dolor afecta a todas las poblaciones, independientemente del sexo, la raza/etnia, los ingresos, la edad o la geografía, no se distribuye de manera uniforme en todo el mundo. Los opioides recetados, incluida la hidrocodona, la oxicodona y la morfina, son potentes medicamentos para reducir el dolor que se utilizan para tratar el dolor causado por lesiones, cirugías y afecciones de salud como el cáncer y la artritis.
El aumento de las prácticas de prescripción de opioides se puede atribuir a los programas de reembolso de seguros que incentivan los opioides sobre los tratamientos alternativos para el dolor, las estructuras de costos que fomentan una atención más eficiente y las evaluaciones que combinan la satisfacción del paciente con un manejo eficaz del dolor. Por lo tanto, debido a la ventaja de los opioides en el manejo del dolor, la demanda está aumentando entre los pacientes con enfermedades crónicas.
Resumen del mercado de opioides en Asia Pacífico
Se estima que la creciente población geriátrica en China que sufre enfermedades terminales aumentará significativamente la demanda de opioides. Según la Organización Mundial de la Salud (OMS), el país tiene una de las poblaciones de envejecimiento de más rápido crecimiento. Según la misma fuente, 254 millones de personas tenían 60 años o más en 2019 y 176 millones de personas tenían 65 años o más. Además, se espera que aproximadamente el 28% de la población (402 millones de personas) en China tenga 60 años o más para 2040 debido al aumento de la esperanza de vida y la disminución de las tasas de natalidad. Las poblaciones geriátricas tienen más probabilidades de experimentar afecciones de salud crónicas asociadas con el dolor, como artritis, dolor de espalda, cáncer, etc. En tales casos, los opioides se utilizan para controlar el dolor crónico en adultos mayores, lo que influye significativamente en el crecimiento del mercado de opioides de Asia Pacífico en China. En China, el número de nuevos pacientes con cáncer que sufren dolor patológico severo ha aumentado significativamente. Según un estudio, \"Impacto de la educación médica continua para médicos en la calidad del tratamiento del dolor oncológico en China\", publicado en 2020, el gobierno de China fomenta el uso de analgésicos opioides para el tratamiento del dolor oncológico moderado a severo, que está ampliamente disponible en hospitales terciarios y secundarios en todo el país. Como los opioides son una parte importante de una escalera analgésica de tres pasos y se recomiendan para aliviar el dolor oncológico moderado y severo, aumentar la conciencia sobre estas afecciones médicas y el tratamiento asociado puede mejorar el plan de tratamiento para el dolor oncológico.
Ingresos y pronóstico del mercado de opioides de Asia Pacífico hasta 2030 (millones de USD)
Segmentación del mercado de opioides de Asia Pacífico
El mercado de opioides de Asia Pacífico se clasifica en producto, aplicación, vía de administración, canal de distribución y país.
Según el producto, el mercado de opioides de Asia Pacífico está segmentado en opioides de liberación inmediata de acción corta y opioides de liberación prolongada de acción prolongada. El segmento de opioides de liberación inmediata y acción corta tuvo una mayor participación de mercado en 2022. El opioide de liberación inmediata y acción corta se subdivide en oxicodona, hidrocodona, tramadol, codina, propoxifeno y otros. El opioide de liberación prolongada y acción prolongada se subdivide en oxicodona, fentanilo, morfina, metadona y otros.
En términos de aplicación, el mercado de opioides de Asia Pacífico se clasifica en manejo del dolor, anestesia, supresión de la diarrea, supresión de la tos, desintoxicación y otros. El segmento de manejo del dolor tuvo la mayor participación de mercado en 2022.
Por vía de administración, el mercado de opioides de Asia Pacífico se segmenta en parches orales, inyectables y transdérmicos. El segmento oral tuvo la mayor participación de mercado en 2022.
Por canal de distribución, el mercado de opioides de Asia Pacífico se bifurca en farmacias hospitalarias y farmacias minoristas. El segmento de farmacias hospitalarias tuvo una mayor participación de mercado en 2022.
Por país, el mercado de opioides de Asia Pacífico está segmentado en China, Japón, India, Corea del Sur, Australia y el resto de Asia Pacífico. China dominó la participación de mercado de opioides de Asia Pacífico en 2022.
Endo International plc, Mallinckrodt Plc, Neuraxpharm Pharmaceuticals SL, Mayne Pharma Group Ltd, Rusan Pharma Ltd y Teva Pharmaceutical Industries Ltd son algunas de las empresas líderes que operan en el mercado de opioides de Asia Pacífico.
TABLE OF CONTENTS
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Asia Pacific Opioids Market - Key Market Dynamics
4.1 Market Drivers
4.1.1 Surging Chronic Pain Incidence
4.1.2 Increasing Geriatric Population
4.2 Market Restraints
4.2.1 Increasing Drug Abuse
4.3 Market Opportunities
4.3.1 Strategic Initiatives by Market Players
4.4 Impact of Drivers and Restraints:
5. Opioids Market - Asia Pacific Analysis
5.1 Asia Pacific Opioids Market Overview
5.2 Asia Pacific Opioids Market Revenue (US$ Million), 2020-2030
5.3 Asia Pacific Opioids Market Forecast Analysis
6. Asia Pacific Opioids Market Analysis - by Product
6.1 Immediate Release Short Acting Opioid
6.1.1 Overview
6.1.2 Immediate Release Short Acting Opioid: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
6.1.2.1 Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid
6.2 Extended Release Long-Acting Opioid
6.2.1 Overview
6.2.2 Extended Release Long-Acting Opioid: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
6.2.2.1 Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long-Acting Opioid
7. Asia Pacific Opioids Market Analysis - by Application
7.1 Pain Management
7.1.1 Overview
7.1.2 Pain Management: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
7.2 Anesthesia
7.2.1 Overview
7.2.2 Anesthesia: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
7.3 Diarrhea Suppression
7.3.1 Overview
7.3.2 Diarrhea Suppression: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Cough Suppression
7.4.1 Overview
7.4.2 Cough Suppression: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
7.5 De-Addiction
7.5.1 Overview
7.5.2 De-Addiction: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
7.6 Others
7.6.1 Overview
7.6.2 Others: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
8. Asia Pacific Opioids Market Analysis - by Route of Administration
8.1 Oral
8.1.1 Overview
8.1.2 Oral: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
8.2 Injectable
8.2.1 Overview
8.2.2 Injectable: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
8.3 Transdermal Patch
8.3.1 Overview
8.3.2 Transdermal Patch: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
9. Asia Pacific Opioids Market Analysis - by Distribution Channel
9.1 Hospital Pharmacies
9.1.1 Overview
9.1.2 Hospital Pharmacies: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
9.2 Retail Pharmacies
9.2.1 Overview
9.2.2 Retail Pharmacies: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
10. Asia Pacific Opioids Market - Country Analysis
10.1 Asia Pacific
10.1.1 Asia Pacific: Opioids Market Breakdown, by Key Countries, 2022 and 2030 (%)
10.1.1.1 Asia Pacific: Opioids Market - Revenue and Forecast Analysis - by Country
10.1.1.2 China: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.2.1 China: Asia Pacific Opioids Market Breakdown, by Product
10.1.1.2.2 China: Asia Pacific Opioids Market Breakdown, by Immediate Release Short Acting Opioid
10.1.1.2.3 China: Asia Pacific Opioids Market Breakdown, by Extended Release Long-Acting Opioid
10.1.1.2.4 China: Asia Pacific Opioids Market Breakdown, by Application
10.1.1.2.5 China: Asia Pacific Opioids Market Breakdown, by Route of Administration
10.1.1.2.6 China: Asia Pacific Opioids Market Breakdown, by Distribution Channel
10.1.1.3 Japan: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.3.1 Japan: Asia Pacific Opioids Market Breakdown, by Product
10.1.1.3.2 Japan: Asia Pacific Opioids Market Breakdown, by Immediate Release Short Acting Opioid
10.1.1.3.3 Japan: Asia Pacific Opioids Market Breakdown, by Extended Release Long-Acting Opioid
10.1.1.3.4 Japan: Asia Pacific Opioids Market Breakdown, by Application
10.1.1.3.5 Japan: Asia Pacific Opioids Market Breakdown, by Route of Administration
10.1.1.3.6 Japan: Asia Pacific Opioids Market Breakdown, by Distribution Channel
10.1.1.4 India: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.4.1 India: Asia Pacific Opioids Market Breakdown, by Product
10.1.1.4.2 India: Asia Pacific Opioids Market Breakdown, by Immediate Release Short Acting Opioid
10.1.1.4.3 India: Asia Pacific Opioids Market Breakdown, by Extended Release Long-Acting Opioid
10.1.1.4.4 India: Asia Pacific Opioids Market Breakdown, by Application
10.1.1.4.5 India: Asia Pacific Opioids Market Breakdown, by Route of Administration
10.1.1.4.6 India: Asia Pacific Opioids Market Breakdown, by Distribution Channel
10.1.1.5 South Korea: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.5.1 South Korea: Asia Pacific Opioids Market Breakdown, by Product
10.1.1.5.2 South Korea: Asia Pacific Opioids Market Breakdown, by Immediate Release Short Acting Opioid
10.1.1.5.3 South Korea: Asia Pacific Opioids Market Breakdown, by Extended Release Long-Acting Opioid
10.1.1.5.4 South Korea: Asia Pacific Opioids Market Breakdown, by Application
10.1.1.5.5 South Korea: Asia Pacific Opioids Market Breakdown, by Route of Administration
10.1.1.5.6 South Korea: Asia Pacific Opioids Market Breakdown, by Distribution Channel
10.1.1.6 Australia: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.6.1 Australia: Asia Pacific Opioids Market Breakdown, by Product
10.1.1.6.2 Australia: Asia Pacific Opioids Market Breakdown, by Immediate Release Short Acting Opioid
10.1.1.6.3 Australia: Asia Pacific Opioids Market Breakdown, by Extended Release Long-Acting Opioid
10.1.1.6.4 Australia: Asia Pacific Opioids Market Breakdown, by Application
10.1.1.6.5 Australia: Asia Pacific Opioids Market Breakdown, by Route of Administration
10.1.1.6.6 Australia: Asia Pacific Opioids Market Breakdown, by Distribution Channel
10.1.1.7 Rest of Asia Pacific: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.7.1 Rest of Asia Pacific: Asia Pacific Opioids Market Breakdown, by Product
10.1.1.7.2 Rest of Asia Pacific: Asia Pacific Opioids Market Breakdown, by Immediate Release Short Acting Opioid
10.1.1.7.3 Rest of Asia Pacific: Asia Pacific Opioids Market Breakdown, by Extended Release Long-Acting Opioid
10.1.1.7.4 Rest of Asia Pacific: Asia Pacific Opioids Market Breakdown, by Application
10.1.1.7.5 Rest of Asia Pacific: Asia Pacific Opioids Market Breakdown, by Route of Administration
10.1.1.7.6 Rest of Asia Pacific: Asia Pacific Opioids Market Breakdown, by Distribution Channel
11. Industry Landscape
11.1 Overview
11.2 Growth Strategies in Opioids Market
11.3 Organic Growth Strategies
11.3.1 Overview
11.4 Inorganic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 Endo International plc
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Mallinckrodt Plc
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Neuraxpharm Pharmaceuticals SL
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Mayne Pharma Group Ltd
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Rusan Pharma Ltd
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Teva Pharmaceutical Industries Ltd
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
?
List of Tables
Table 1. Asia Pacific Opioids Market Segmentation
Table 2. Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Table 3. Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Product
Table 4. Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid
Table 5. Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long-Acting Opioid
Table 6. Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Application
Table 7. Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Route of Administration
Table 8. Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel
Table 9. Asia Pacific: Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Country
Table 10. China: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Product
Table 11. China: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid
Table 12. China: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long-Acting Opioid
Table 13. China: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Application
Table 14. China: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Route of Administration
Table 15. China: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel
Table 16. Japan: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Product
Table 17. Japan: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid
Table 18. Japan: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long-Acting Opioid
Table 19. Japan: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Application
Table 20. Japan: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Route of Administration
Table 21. Japan: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel
Table 22. India: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Product
Table 23. India: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid
Table 24. India: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long-Acting Opioid
Table 25. India: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Application
Table 26. India: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Route of Administration
Table 27. India: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel
Table 28. South Korea: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Product
Table 29. South Korea: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid
Table 30. South Korea: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long-Acting Opioid
Table 31. South Korea: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Application
Table 32. South Korea: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Route of Administration
Table 33. South Korea: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel
Table 34. Australia: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Product
Table 35. Australia: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid
Table 36. Australia: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long-Acting Opioid
Table 37. Australia: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Application
Table 38. Australia: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Route of Administration
Table 39. Australia: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel
Table 40. Rest of Asia Pacific: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Product
Table 41. Rest of Asia Pacific: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid
Table 42. Rest of Asia Pacific: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long-Acting Opioid
Table 43. Rest of Asia Pacific: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Application
Table 44. Rest of Asia Pacific: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Route of Administration
Table 45. Rest of Asia Pacific: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel
Table 46. Recent Organic Growth Strategies in Opioids Market
Table 47. Recent Inorganic Growth Strategies in the Opioids Market
Table 48. Glossary of Terms, Opioids Market
?
List of Figures
Figure 1. Asia Pacific Opioids Market Segmentation, by Country
Figure 2. Asia Pacific Opioids Market - Key Market Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Asia Pacific Opioids Market Revenue (US$ Million), 2020-2030
Figure 5. Asia Pacific Opioids Market Share (%) - by Product (2022 and 2030)
Figure 6. Immediate Release Short Acting Opioid: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Extended Release Long-Acting Opioid: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Asia Pacific Opioids Market Share (%) - by Application (2022 and 2030)
Figure 9. Pain Management: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. Anesthesia: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Diarrhea Suppression: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Cough Suppression: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. De-Addiction: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Others: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Asia Pacific Opioids Market Share (%) - by Route of Administration (2022 and 2030)
Figure 16. Oral: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Injectable: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Transdermal Patch: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. Asia Pacific Opioids Market Share (%) - by Distribution Channel (2022 and 2030)
Figure 20. Hospital Pharmacies: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. Retail Pharmacies: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. Asia Pacific: Opioids Market, by Key Countries - Revenue (2022) (US$ Million)
Figure 23. Asia Pacific: Opioids Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 24. China: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 25. Japan: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 26. India: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 27. South Korea: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 28. Australia: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 29. Rest of Asia Pacific: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 30. Growth Strategies in Opioids Market
- Endo International plc
- Mallinckrodt Plc
- Neuraxpharm Pharmaceuticals SL
- Mayne Pharma Group Ltd
- Rusan Pharma Ltd
- Teva Pharmaceutical Industries Ltd
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific opioids market.
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific opioids market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the Asia Pacific opioids market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.